The regulatory role of TGF-β in airway remodeling in asthma

Toluwalope Makinde, Richard F. Murphy, Devendra K. Agrawal

Research output: Contribution to journalReview article

172 Citations (Scopus)

Abstract

Both structural and inflammatory cells are capable of secreting transforming growth factor (TGF)-β and expressing TGF-β receptors. TGF-β can induce multiple cellular responses including differentiation, apoptosis, survival and proliferation, and has been implicated in the development of several pathogenic conditions including cancer and asthma. Elevated levels of TGF-β have been reported in the asthmatic airway. TGF-β binds to its receptor complex and activates multiple pathways involving proteins such as Sma and Mad homologues, phosphatidylinositol-3 kinase and the mitogen-activated protein kinases, leading to the transcription of several genes. Cell type, cellular condition, and microenvironment, all play a role in determining which pathway is activated, which, in turn, is an indication of which gene is to be transcribed. TGF-β has been shown to induce apoptosis in airway epithelial cells. A possible role for TGF-β in the regulation of epithelial cell adhesion properties has also been reported. Enhancement of goblet cell proliferation by TGF-β suggests a role in mucus hyper-secretion. Elevated levels of TGF-β correlate with subepithelial fibrosis. TGF-β induces proliferation of fibroblast cells and their differentiation into myofibroblasts and extracellular matrix (ECM) protein synthesis during the development of subepithelial fibrosis. TGF-β also induces proliferation and survival of and ECM secretion in airway smooth muscle cells (ASMCs), suggesting a possible cause of increased thickness of airway tissues. TGF-β also induces the production and release of vascular endothelial cell growth factor and plasminogen activator inhibitor, contributing to the vascular remodeling in the asthmatic airway. Blocking TGF-β activity inhibits epithelial shedding, mucus hyper-secretion, angiogenesis, ASMC hypertrophy and hyperplasia in an asthmatic mouse model. Reduction of TGF-β production and control of TGF-β effects would be beneficial in the development of therapeutic intervention for airway remodeling in chronic asthma.

Original languageEnglish
Pages (from-to)348-356
Number of pages9
JournalImmunology and Cell Biology
Volume85
Issue number5
DOIs
StatePublished - Jul 2007

Fingerprint

Airway Remodeling
Transforming Growth Factors
Asthma
Mucus
Smooth Muscle Myocytes
Muscle
Fibrosis
Genes
Epithelial Cells
Cells
Phosphatidylinositol 3-Kinase
Apoptosis
Cellular Microenvironment
Plasminogen Inactivators
Goblet Cells
Myofibroblasts
Growth Factor Receptors
Extracellular Matrix Proteins
Cell adhesion
Endothelial cells

All Science Journal Classification (ASJC) codes

  • Cell Biology
  • Clinical Biochemistry
  • Immunology

Cite this

The regulatory role of TGF-β in airway remodeling in asthma. / Makinde, Toluwalope; Murphy, Richard F.; Agrawal, Devendra K.

In: Immunology and Cell Biology, Vol. 85, No. 5, 07.2007, p. 348-356.

Research output: Contribution to journalReview article

Makinde, Toluwalope ; Murphy, Richard F. ; Agrawal, Devendra K. / The regulatory role of TGF-β in airway remodeling in asthma. In: Immunology and Cell Biology. 2007 ; Vol. 85, No. 5. pp. 348-356.
@article{8eeee29af2954c59b02c300dae8ab0ea,
title = "The regulatory role of TGF-β in airway remodeling in asthma",
abstract = "Both structural and inflammatory cells are capable of secreting transforming growth factor (TGF)-β and expressing TGF-β receptors. TGF-β can induce multiple cellular responses including differentiation, apoptosis, survival and proliferation, and has been implicated in the development of several pathogenic conditions including cancer and asthma. Elevated levels of TGF-β have been reported in the asthmatic airway. TGF-β binds to its receptor complex and activates multiple pathways involving proteins such as Sma and Mad homologues, phosphatidylinositol-3 kinase and the mitogen-activated protein kinases, leading to the transcription of several genes. Cell type, cellular condition, and microenvironment, all play a role in determining which pathway is activated, which, in turn, is an indication of which gene is to be transcribed. TGF-β has been shown to induce apoptosis in airway epithelial cells. A possible role for TGF-β in the regulation of epithelial cell adhesion properties has also been reported. Enhancement of goblet cell proliferation by TGF-β suggests a role in mucus hyper-secretion. Elevated levels of TGF-β correlate with subepithelial fibrosis. TGF-β induces proliferation of fibroblast cells and their differentiation into myofibroblasts and extracellular matrix (ECM) protein synthesis during the development of subepithelial fibrosis. TGF-β also induces proliferation and survival of and ECM secretion in airway smooth muscle cells (ASMCs), suggesting a possible cause of increased thickness of airway tissues. TGF-β also induces the production and release of vascular endothelial cell growth factor and plasminogen activator inhibitor, contributing to the vascular remodeling in the asthmatic airway. Blocking TGF-β activity inhibits epithelial shedding, mucus hyper-secretion, angiogenesis, ASMC hypertrophy and hyperplasia in an asthmatic mouse model. Reduction of TGF-β production and control of TGF-β effects would be beneficial in the development of therapeutic intervention for airway remodeling in chronic asthma.",
author = "Toluwalope Makinde and Murphy, {Richard F.} and Agrawal, {Devendra K.}",
year = "2007",
month = "7",
doi = "10.1038/sj.icb.7100044",
language = "English",
volume = "85",
pages = "348--356",
journal = "Immunology and Cell Biology",
issn = "0818-9641",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - The regulatory role of TGF-β in airway remodeling in asthma

AU - Makinde, Toluwalope

AU - Murphy, Richard F.

AU - Agrawal, Devendra K.

PY - 2007/7

Y1 - 2007/7

N2 - Both structural and inflammatory cells are capable of secreting transforming growth factor (TGF)-β and expressing TGF-β receptors. TGF-β can induce multiple cellular responses including differentiation, apoptosis, survival and proliferation, and has been implicated in the development of several pathogenic conditions including cancer and asthma. Elevated levels of TGF-β have been reported in the asthmatic airway. TGF-β binds to its receptor complex and activates multiple pathways involving proteins such as Sma and Mad homologues, phosphatidylinositol-3 kinase and the mitogen-activated protein kinases, leading to the transcription of several genes. Cell type, cellular condition, and microenvironment, all play a role in determining which pathway is activated, which, in turn, is an indication of which gene is to be transcribed. TGF-β has been shown to induce apoptosis in airway epithelial cells. A possible role for TGF-β in the regulation of epithelial cell adhesion properties has also been reported. Enhancement of goblet cell proliferation by TGF-β suggests a role in mucus hyper-secretion. Elevated levels of TGF-β correlate with subepithelial fibrosis. TGF-β induces proliferation of fibroblast cells and their differentiation into myofibroblasts and extracellular matrix (ECM) protein synthesis during the development of subepithelial fibrosis. TGF-β also induces proliferation and survival of and ECM secretion in airway smooth muscle cells (ASMCs), suggesting a possible cause of increased thickness of airway tissues. TGF-β also induces the production and release of vascular endothelial cell growth factor and plasminogen activator inhibitor, contributing to the vascular remodeling in the asthmatic airway. Blocking TGF-β activity inhibits epithelial shedding, mucus hyper-secretion, angiogenesis, ASMC hypertrophy and hyperplasia in an asthmatic mouse model. Reduction of TGF-β production and control of TGF-β effects would be beneficial in the development of therapeutic intervention for airway remodeling in chronic asthma.

AB - Both structural and inflammatory cells are capable of secreting transforming growth factor (TGF)-β and expressing TGF-β receptors. TGF-β can induce multiple cellular responses including differentiation, apoptosis, survival and proliferation, and has been implicated in the development of several pathogenic conditions including cancer and asthma. Elevated levels of TGF-β have been reported in the asthmatic airway. TGF-β binds to its receptor complex and activates multiple pathways involving proteins such as Sma and Mad homologues, phosphatidylinositol-3 kinase and the mitogen-activated protein kinases, leading to the transcription of several genes. Cell type, cellular condition, and microenvironment, all play a role in determining which pathway is activated, which, in turn, is an indication of which gene is to be transcribed. TGF-β has been shown to induce apoptosis in airway epithelial cells. A possible role for TGF-β in the regulation of epithelial cell adhesion properties has also been reported. Enhancement of goblet cell proliferation by TGF-β suggests a role in mucus hyper-secretion. Elevated levels of TGF-β correlate with subepithelial fibrosis. TGF-β induces proliferation of fibroblast cells and their differentiation into myofibroblasts and extracellular matrix (ECM) protein synthesis during the development of subepithelial fibrosis. TGF-β also induces proliferation and survival of and ECM secretion in airway smooth muscle cells (ASMCs), suggesting a possible cause of increased thickness of airway tissues. TGF-β also induces the production and release of vascular endothelial cell growth factor and plasminogen activator inhibitor, contributing to the vascular remodeling in the asthmatic airway. Blocking TGF-β activity inhibits epithelial shedding, mucus hyper-secretion, angiogenesis, ASMC hypertrophy and hyperplasia in an asthmatic mouse model. Reduction of TGF-β production and control of TGF-β effects would be beneficial in the development of therapeutic intervention for airway remodeling in chronic asthma.

UR - http://www.scopus.com/inward/record.url?scp=34447116385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447116385&partnerID=8YFLogxK

U2 - 10.1038/sj.icb.7100044

DO - 10.1038/sj.icb.7100044

M3 - Review article

VL - 85

SP - 348

EP - 356

JO - Immunology and Cell Biology

JF - Immunology and Cell Biology

SN - 0818-9641

IS - 5

ER -